Director Shareholding
June 26 2003 - 2:14PM
UK Regulatory
RNS Number:8555M
Keryx Biopharmaceuticals Inc
26 June 2003
Keryx Biopharmaceuticals, INC ("the Company")
Grants of Options to Non-Executive Directors
On June 23, 2003, the company granted the following options to its non-executive
directors pursuant to its 2000 Stock Option Plan automatic grant provisions for
non-executive directors. The options were granted at an exercise price of $1.92
per share and vest over the next year.
Name Initial Grant Annual Grant
Lawrence J. Kessel, M.D. 25,000 ----
Peter Salomon, M.D. 25,000 ----
Lindsay A. Rosenwald, M.D. ---- 5,000
Peter M. Kash ---- 5,000
Malcolm Hoenlein ---- 5,000
26 June, 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSVQLFLXQBFBBL